{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:40:52Z","timestamp":1778503252403,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019155","name":"Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","soard.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery for Obesity and Related Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.soard.2024.09.013","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T15:12:23Z","timestamp":1728745943000},"page":"247-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-7720","authenticated-orcid":false,"given":"Xiaodong","family":"Shan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4597-9175","authenticated-orcid":false,"given":"Xiaoao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4835-1956","authenticated-orcid":false,"given":"Yuanqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xitai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.soard.2024.09.013_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/aas.12884","article-title":"Post-operative nausea and vomiting in bariatric surgery patients: an observational study","volume":"61","author":"Halliday","year":"2017","journal-title":"Acta Anaesthesiol Scand"},{"issue":"7","key":"10.1016\/j.soard.2024.09.013_bib2","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1007\/s00464-019-07058-5","article-title":"The impact of nausea on post-operative outcomes in bariatric surgery patients","volume":"34","author":"Suh","year":"2020","journal-title":"Surg Endosc"},{"issue":"3","key":"10.1016\/j.soard.2024.09.013_bib3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11695-021-05859-z","article-title":"Preoperative reflux or regurgitation symptoms are independent predictors of postoperative nausea and vomiting (PONV) in patients undergoing bariatric surgery: a propensity score matching analysis","volume":"32","author":"Zhu","year":"2022","journal-title":"Obes Surg"},{"issue":"10","key":"10.1016\/j.soard.2024.09.013_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.soard.2020.05.017","article-title":"Assessment of postoperative nausea and vomiting after bariatric surgery using a validated questionnaire","volume":"16","author":"Kushner","year":"2020","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"10.1016\/j.soard.2024.09.013_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/SLA.0000000000002079","article-title":"Prevalence and risk factors for bariatric surgery readmissions: findings from 130,007 admissions in the metabolic and bariatric surgery accreditation and quality improvement program","volume":"267","author":"Berger","year":"2018","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.soard.2024.09.013_bib6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.soard.2021.08.005","article-title":"Postoperative nausea and vomiting in bariatric surgery: a position statement endorsed by the ASMBS and the ISPCOP","volume":"17","author":"Schumann","year":"2021","journal-title":"Surg Obes Relat Dis"},{"issue":"3","key":"10.1016\/j.soard.2024.09.013_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13543","article-title":"Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: a network meta-analysis of randomized clinical trials","volume":"24","author":"Alkhezi","year":"2023","journal-title":"Obes Rev"},{"key":"10.1016\/j.soard.2024.09.013_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes\u2014state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.soard.2024.09.013_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1043789","article-title":"Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.soard.2024.09.013_bib10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/dom.12824","article-title":"Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: a systematic analysis of published clinical trials","volume":"19","author":"Bettge","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.soard.2024.09.013_bib11","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1530\/EJE-19-0566","article-title":"Management of endocrine disease: are all GLP-1 agonists equal in the treatment of type 2 diabetes?","volume":"181","author":"Nauck","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.soard.2024.09.013_bib12","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s11695-013-0923-1","article-title":"The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial","volume":"23","author":"Benevides","year":"2013","journal-title":"Obes Surg"},{"issue":"6","key":"10.1016\/j.soard.2024.09.013_bib13","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1007\/s00464-023-09939-2","article-title":"Effects of ondansetron, metoclopramide and granisetron on perioperative nausea and vomiting in patients undergone bariatric surgery: a randomized clinical trial","volume":"37","author":"Ebrahimian","year":"2023","journal-title":"Surg Endosc"},{"issue":"4","key":"10.1016\/j.soard.2024.09.013_bib14","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s11695-024-07129-0","article-title":"The impact of aprepitant on nausea and vomiting following laparoscopic sleeve gastrectomy: a blinded randomized controlled trial","volume":"34","author":"Ortiz","year":"2024","journal-title":"Obes Surg"},{"issue":"1","key":"10.1016\/j.soard.2024.09.013_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11695-017-2797-0","article-title":"The role of aprepitant in prevention of postoperative nausea and vomiting after bariatric surgery","volume":"28","author":"Therneau","year":"2018","journal-title":"Obes Surg"},{"issue":"11","key":"10.1016\/j.soard.2024.09.013_bib16","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1007\/s11695-020-04795-8","article-title":"A comprehensive approach for the prevention of nausea and vomiting following sleeve gastrectomy: a randomized controlled trial","volume":"30","author":"Spaniolas","year":"2020","journal-title":"Obes Surg"},{"issue":"10","key":"10.1016\/j.soard.2024.09.013_bib17","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1007\/s11695-021-05589-2","article-title":"Prophylactic administration of diphenhydramine\/acetaminophen and ondansetron reduced postoperative nausea and vomiting and pain following laparoscopic sleeve gastrectomy: a randomized controlled trial","volume":"31","author":"Pourfakhr","year":"2021","journal-title":"Obes Surg"},{"issue":"2","key":"10.1016\/j.soard.2024.09.013_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1213\/ANE.0000000000004833","article-title":"Fourth consensus guidelines for the management of postoperative nausea and vomiting","volume":"131","author":"Gan","year":"2020","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.soard.2024.09.013_bib19","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1038\/s41598-023-34992-1","article-title":"The risk factors of postoperative nausea and vomiting in patients undergoing laparoscopic sleeve gastrectomy and laparoscopic distal gastrectomy: a propensity score matching analysis","volume":"13","author":"Chen","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.soard.2024.09.013_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/dom.12824","article-title":"Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: a systematic analysis of published clinical trials","volume":"19","author":"Bettge","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.soard.2024.09.013_bib21","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/oby.23481","article-title":"Effects of liraglutide on gastrointestinal functions and weight in obesity: a randomized clinical and pharmacogenomic trial","volume":"30","author":"Maselli","year":"2022","journal-title":"Obesity"},{"issue":"6","key":"10.1016\/j.soard.2024.09.013_bib22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ijo.2013.162","article-title":"Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults","volume":"38","author":"van Can","year":"2014","journal-title":"Int J Obes"},{"issue":"12","key":"10.1016\/j.soard.2024.09.013_bib23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","article-title":"Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial","volume":"2","author":"Halawi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.soard.2024.09.013_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/dom.13120","article-title":"Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity","volume":"20","author":"Hjerpsted","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.soard.2024.09.013_bib25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.soard.2024.09.013_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/dom.13927","article-title":"Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial","volume":"22","author":"Hulst","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.soard.2024.09.013_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuron.2020.11.010","article-title":"Area postrema cell types that mediate nausea-associated behaviors","volume":"109","author":"Zhang","year":"2021","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.soard.2024.09.013_bib28","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1523\/JNEUROSCI.23-07-02939.2003","article-title":"Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites","volume":"23","author":"Yamamoto","year":"2003","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.soard.2024.09.013_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.diabet.2017.05.009","article-title":"Effect of GLP-1 receptor agonist on gastrointestinal tract motility and residue rates as evaluated by capsule endoscopy","volume":"43","author":"Nakatani","year":"2017","journal-title":"Diabetes Metab"},{"issue":"4","key":"10.1016\/j.soard.2024.09.013_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MCG.0000000000001485","article-title":"Nausea and vomiting in 2021: a comprehensive update","volume":"55","author":"Heckroth","year":"2021","journal-title":"J Clin Gastroenterol"},{"issue":"16","key":"10.1016\/j.soard.2024.09.013_bib31","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2174\/13816128113199990568","article-title":"The medical implications of gastrointestinal vagal afferent pathways in nausea and vomiting","volume":"20","author":"Horn","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"9","key":"10.1016\/j.soard.2024.09.013_bib32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1592\/phco.31.9.896","article-title":"Liraglutide: clinical pharmacology and considerations for therapy","volume":"31","author":"Sisson","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"18","key":"10.1016\/j.soard.2024.09.013_bib33","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.soard.2024.09.013_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2017.03.020","article-title":"Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species","volume":"104","author":"Jensen","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.soard.2024.09.013_bib35","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.2147\/DDDT.S470826","article-title":"Clinical pharmacokinetics of semaglutide: a systematic review","volume":"18","author":"Yang","year":"2024","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.soard.2024.09.013_bib36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s12325-020-01548-y","article-title":"pharmacokinetics, safety and tolerability of once-weekly subcutaneous semaglutide in healthy chinese subjects: a double-blind, phase 1, randomized controlled trial","volume":"38","author":"Shi","year":"2021","journal-title":"Adv Ther"}],"container-title":["Surgery for Obesity and Related Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728924008426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728924008426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:14:27Z","timestamp":1738800867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550728924008426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1550728924008426"],"URL":"https:\/\/doi.org\/10.1016\/j.soard.2024.09.013","relation":{},"ISSN":["1550-7289"],"issn-type":[{"value":"1550-7289","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Surgery for Obesity and Related Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soard.2024.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}